Causal role of mitochondrial proteins in aortic aneurysms: Evidence from Mendelian randomization, transcriptomic

Adilai Abodulikemu1, Li Li2, Mukamengjiang Juaiti2

  • 1Department of Coronary Care Unit, Traditional Chinese Medical Hospital of Xinjiang Uygur Autonomous Region, The Affiliated Hospital of Traditional Chinese Medicine of Xinjiang Medical University, Urumqi, China.

Medicine
|March 11, 2025
PubMed

Insights

This study used Mendelian randomization to identify mitochondrial proteins causally linked to aortic aneurysms (AA). Iron-sulfur cluster assembly enzyme (ISCU), MRPL14, and MSRA were found to be associated with AA pathogenesis.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Mitochondrial dysfunction is implicated in aortic aneurysm (AA) development.
  • The specific causal roles of mitochondrial proteins in AA pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate the potential causal relationship between genetically predicted mitochondrial proteins and the risk of aortic aneurysms (AA).
  • To identify specific mitochondrial proteins that may serve as therapeutic targets or biomarkers for AA.

Main Methods:

  • Employed a Mendelian randomization (MR) approach using genetic data from the IEU OpenGWAS database and FinnGen biobank.
  • Utilized inverse-variance weighting (IVW) as the primary analysis method, with MR-Egger and weighted median as sensitivity analyses.
  • Performed replication using GWAS Catalog data, meta-analysis, gene expression validation (GEO), gene set enrichment analysis (GSEA), and in vitro experiments.

Main Results:

  • Identified three mitochondrial proteins causally associated with AA: iron-sulfur cluster assembly enzyme (ISCU), 39S ribosomal protein L14 (MRPL14), and mitochondrial peptide methionine sulfoxide reductase (MSRA).
  • Sensitivity analyses confirmed the robustness of findings, ruling out heterogeneity, pleiotropy, and reverse causation.
  • Gene expression analysis showed ISCU upregulation and MRPL14/MSRA downregulation in AA tissues, with pathways related to inflammation and vascular remodeling implicated.

Conclusions:

  • Provides robust genetic and experimental evidence for the causal roles of ISCU, MRPL14, and MSRA in the pathogenesis of aortic aneurysms.
  • These identified mitochondrial proteins represent potential novel biomarkers and therapeutic targets for aortic aneurysms.
  • Further research is warranted to explore the clinical utility of these findings in AA management.